Leadership
Our executive team
![](https://elixiahealth.com/wp-content/uploads/2024/06/dustin-min-uai-258x258-1.png)
Dustin Owen
Chief Executive Officer
Dustin’s strategic vision and leadership are poised to drive Elixia’s global growth and innovation. His commitment to inclusive, patient-centric research makes him the ideal leader to helm Elixia into its next era of excellence.
![](https://elixiahealth.com/wp-content/uploads/2023/06/neal-min-uai-258x258.png)
Neal A. Patel
Chief Strategic Growth Officer and President, Clinical Research Sites
Under his leadership, Elixia’s total enterprise value has more than quadrupled, the number of employees tripled and the company has received numerous accolades for its work across several therapeutic focuses.
![](https://elixiahealth.com/wp-content/uploads/2023/06/jim-min-uai-258x258.png)
Jim F. Crissy
Chief Operating Officer, Clinical Research Sites
In his role of COO for Elixia, Jim provides strategic direction and operational oversight to a diverse and unique system of logistics that reflects the disruptive nature of Elixia’s forward approach to clinical trials.
![](https://elixiahealth.com/wp-content/uploads/2024/06/sarah-min-uai-258x258-1.png)
Sarah Petrucci
Chief Financial Officer
Sarah is the driving force behind our aggressive growth strategy. Her expertise ensures Elixia’s financial health is robust, perfectly positioning us to become a leading clinical trial site organization.
![](https://elixiahealth.com/wp-content/uploads/2023/06/Leadership-Alcorn-Headshot-uai-258x258.png)
Harry Alcorn
Chief Scientific Officer, Clinical Research Sites
Harry masterfully orchestrates the fusion of operational strategy and scientific innovation with deep-rooted industry expertise. His command of our Early Phase Clinical Trials Division underpins Elixia’s leadership in niche-focused clinical trials.
Management Team
![](https://elixiahealth.com/wp-content/uploads/2024/02/sahil-mehta-uai-258x258.png)
Sahil Mehta
VP of Strategic Operations
![](https://elixiahealth.com/wp-content/uploads/2024/04/dalia-vrooman-min-uai-258x258.png)
Dalia Vrooman
Director of Patient Engagement and Inclusion
![](https://elixiahealth.com/wp-content/uploads/2024/02/dolly-rivera-uai-258x258.png)
Dolly Rivera
VP of Site Network Advancement
![](https://elixiahealth.com/wp-content/uploads/2024/02/Isabel-castano-uai-258x258.png)
Isabel Castano
Head of Quality Assurance Division
![](https://elixiahealth.com/wp-content/uploads/2024/04/elisabeth-revera-min-1-uai-258x258.png)
Elisabeth Rivera
Trial Excellence and Site Success
![](https://elixiahealth.com/wp-content/uploads/2023/06/Leadership-Callout-scaled-uai-258x159.jpg)
UNCONVENTIONAL. RESTLESS. DISRUPTIVE.
“When we talk about ‘disruption,’ we mean replacing the traditional model with a new gold standard for operational processes, patient recruitment, site management, and all the things that have forever plagued pharma. We are redefining expectations about what is possible in clinical development in terms of speed, reliability, scalability and reproducibility. Elixia does only a few things and we do them really well. We have to, because what’s on the line for our clients is missing timelines, a lack of diversity, or even failed trials. Clients and patients deserve more.”
![null](https://elixiahealth.com/wp-content/uploads/2023/04/Website-Headshots-1.webp)